CME Group Appoints John P. McNulty to Board

Ticker: CME · Form: 8-K · Filed: 2024-07-08T00:00:00.000Z

Sentiment: neutral

Topics: board-appointment, governance

Related Tickers: CME

TL;DR

CME adds new board member John P. McNulty, ex-JPMorgan, effective July 8.

AI Summary

CME Group Inc. announced on July 8, 2024, the appointment of John P. McNulty as a new Class II Director, effective immediately. McNulty, who will serve on the Audit and Compensation Committees, brings extensive experience from his tenure at JPMorgan Chase & Co. and as a former Senior Independent Director at the London Stock Exchange Group.

Why It Matters

The addition of a director with significant financial and exchange experience could influence strategic decisions and governance at CME Group.

Risk Assessment

Risk Level: low — The filing is an 8-K reporting a routine board appointment, not a significant financial event.

Key Players & Entities

CME Group Inc. (company) — Registrant
John P. McNulty (person) — Newly appointed Class II Director
JPMorgan Chase & Co. (company) — Former employer of John P. McNulty
London Stock Exchange Group (company) — Former employer of John P. McNulty
July 8, 2024 (date) — Effective date of appointment

FAQ

Who is John P. McNulty and what is his background?

John P. McNulty is a newly appointed Class II Director for CME Group Inc. He has a background as a former Senior Independent Director at the London Stock Exchange Group and previously held roles at JPMorgan Chase & Co.

When was John P. McNulty's appointment effective?

John P. McNulty's appointment was effective immediately as of July 8, 2024.

Which committees will John P. McNulty serve on?

John P. McNulty will serve on the Audit Committee and the Compensation Committee.

What is CME Group Inc.'s principal executive office address?

CME Group Inc.'s principal executive offices are located at 20 South Wacker Drive, Chicago, Illinois 60606.

What is the SEC file number for CME Group Inc.'s 8-K filing?

The SEC file number for this 8-K filing is 001-31553.

From the Filing

0001193125-24-175987.txt : 20240708 0001193125-24-175987.hdr.sgml : 20240708 20240708100931 ACCESSION NUMBER: 0001193125-24-175987 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240708 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240708 DATE AS OF CHANGE: 20240708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CME GROUP INC. CENTRAL INDEX KEY: 0001156375 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200] ORGANIZATION NAME: 02 Finance IRS NUMBER: 364459170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31553 FILM NUMBER: 241103586 BUSINESS ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3129301000 MAIL ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC DATE OF NAME CHANGE: 20010802 8-K 1 d410549d8k.htm 8-K 8-K false 0001156375 0001156375 2024-07-08 2024-07-08     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 8, 2024 ( July 8, 2024 )     CME GROUP INC. (Exact Name of Registrant as Specified in its Charter)       Delaware   001-31553   36-4459170 (State or Other Jurisdiction of Incorporation)   (Commission File No.)   (IRS Employer Identification No.)   20 South Wacker Drive   Chicago   Illinois    60606 (Address of Principal Executive Offices)        (Zip Code) Registrant’s telephone number, including area code: (312) 930-1000 N/A (Former Name or Former Address, if Changed Since Last Report)     Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol   Name of each exchange on which registered Class A Common Stock   CME   Nasdaq Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As described in the attached press release, Michael G. Dennis will be joining CME Group Inc. (the “CME Group” or the “Company”) as of August 5, 2024 in the role of Senior Managing Director Global Head, Fixed Income. In